Director, New Product Launch Strategy

Job overview

The Director, New Product Launch Strategy role is hybrid or remote, with the listing based in Sunnyvale, CA; compensation is $211,000–$241,000 per year. Ceribell develops point-of-care EEG technology for patients with serious neurological conditions. The director owns the go-to-market roadmap for new features, product extensions, and indications, helping drive commercial adoption and customer success. The role aligns Product, Marketing, Sales, and Customer Success around positioning, market opportunities, and launch decisions, using customer and field insights to inform product direction.

What you'll do

• Own the comprehensive go-to-market roadmap and strategy aligned with growth and revenue objectives
• oversee market analysis for trends, competitive threats, and growth opportunities
• establish product positioning and value propositions
• align Product, Sales, Marketing, and Customer Success
• synthesize insights from field engagement, key opinion leaders, and customer advisory boards to inform product roadmaps.

What we're looking for

Skills & competencies

product launch strategy

go-to-market

director

medical technology

eeg

product positioning

commercial adoption

hybrid or remote

sunnyvale ca

$211k–$241k/year

travel required

Work arrangement

• Weekend coverage required

Benefits & perks

• Performance-based incentive compensation, equity opportunities, employer-paid employee health benefits, dependent health/dental/vision contributions, life and long-term disability insurance, 401(k) match, employee stock purchase plan, cell phone stipend, flexible paid time off, paid holidays, wellness days, and parental leave.

Why this role

Hybrid or remote arrangement; travel for customer engagement, industry events, and headquarters collaboration is required, typically 1–2 weeks per month.

About the employer

Ceribell, Inc is hiring for this role. Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology). Sector: 54.